Cherwell improves support for pharmaceutical microbiology in Republic of Ireland
Redipor Prepared Media from Cherwell Laboratories
Redipor prepared media to be supplied directly to customers.
Cherwell Laboratories will now be delivering their Redipor prepared media directly to customers in the Republic of Ireland. Cherwell are renowned for offering a flexible supply of quality prepared microbiological media products, and this development will now enable Cherwell to offer improved service and support to customers in the Republic of Ireland.
Since some of the leading international names in the pharmaceutical industry operate manufacturing sites in Ireland, Cherwell recognises the importance of this market for environmental monitoring, product sterility testing, as well as operator and process validation. Andy Whittard, Managing Director, Cherwell Laboratories commented: “Our recent investment in resources and expertise within the company now allows us to focus on regions where our Redipor product is not established. By developing closer relationship with customers it will allow us to ensure we deliver the best prepared media solutions and dedicated customer service.” Cherwell will now ship Redipor product directly from their UK manufacturing facility in Oxfordshire to customers in the Republic of Ireland.
To further enhance their customer service and support in that region, Cherwell are also currently recruiting for a Sales Specialist, based in the Republic of Ireland. Cherwell Laboratories’ Sales Manager, Andrew Barrow remarked: “While we pride ourselves on the customer service we provide by phone and email, we appreciate the importance of having support locally that customers can contact. Fulfilling this new role will help us to build and maintain links with customers, allowing us to fully understand and satisfy their needs.” Cherwell will continue to work with their distributor in Belfast, Davidson & Hardy, for the supply of Redipor products in Northern Ireland.
Further demonstrating their commitment to the Irish market, Cherwell have also recently become a corporate member of the Irish Cleanroom Society. The society provides a forum for the exchange of ideas and working practices, a support network and works closely with the Cleanroom Testing and Certification Board to run a series of training courses.
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...